Among them was David Liu, a biochemist at the Broad Institute and Harvard University in Cambridge, Massachusetts. Liu isn’t a ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford ...
Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...
Epstein sought to use his own genetic material for regenerative medicine, following his conviction for soliciting ...
3d
Epstein paid for novel genetic testing in apparent effort to explore extending life, new emails show
Convicted sex offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his own genetic material for ...
Rising day and night temperatures are threatening rice, wheat, and maize production by disrupting plant growth, grain filling, and grain quality, putting global food security at risk. Precision ...
At Web Summit Qatar, AI-powered biotech startups describe how automation, data, and gene editing are filling labor gaps in ...
Cibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resistance to Light Leaf Spot disease, which has ...
With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...
The late sex offender had a secret eugenics obsession. His plan? Genetically engineer children using his own sperm ...
Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.
Dr Stephen Ward, CTO of Cell and Gene Therapy Catapult, and Dr Annarita Miccio, managing director at Imagine Institute for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results